Back to Markets
RLRelay Therapeutics Inc

Relay Therapeutics Inc

RLAYNASDAQ NMS - GLOBAL MARKET
Health CareBiotechnology

$14.05

+0.1500 (+1.08%)

As of 05/29/26 EDT · USD

Compare
Low: $2.93Current: $14.05High: $17.32

Key Statistics

Open

$13.77

Day High

$14.38

Day Low

$13.60

Prev. Close

$13.90

VolumeShares traded today.

3.26M

Avg. VolumeAverage daily volume.

Market CapTotal value of all shares = price × shares outstanding.

$3.03B

P/E (TTM)Price-to-Earnings: share price ÷ earnings per share over the last 12 months. Lower can mean cheaper; very high can mean growth expectations.

-8.98

Forward P/EP/E based on forecast next-year earnings.

P/B RatioPrice-to-Book: share price ÷ book value per share.

52W HighHighest price over the past 52 weeks.

$17.32

52W LowLowest price over the past 52 weeks.

$2.93

50D MAAverage closing price over the last 50 trading days.

$13.10

200D MAAverage closing price over the last 200 trading days.

$8.53

Dividend YieldAnnual dividend ÷ share price, as a %.

BetaVolatility vs the market. >1 = more volatile than the S&P 500.

Performance

1W

+2.9%

1M

+11.8%

6M

+74.5%

YTD

+71.8%

1Y

+341.8%

About

Martin Shkreli is an American investor and businessman. Shkreli is the co-founder of the hedge funds Elea Capital, MSMB Capital Management, and MSMB Healthcare, the co-founder and former CEO of pharmaceutical firms Retrophin and Turing Pharmaceuticals, and the former CEO of start-up software company Gödel Systems, which he founded in August 2016.

relaytx.com/

Company Facts

SectorHealth Care
IndustryBiotechnology
ExchangeNASDAQ NMS - GLOBAL MARKET
CurrencyUSD

Sentiment

Latest News

Social Noise

Price Alerts

Loading…

Trade RLAY

Brokers available in your region (US)

Affiliate links — we may earn a commission. CFDs are risky.